Back to Search
Start Over
Cancer Risk in Transgender People.
- Source :
-
Endocrinology and metabolism clinics of North America [Endocrinol Metab Clin North Am] 2019 Jun; Vol. 48 (2), pp. 441-452. Date of Electronic Publication: 2019 Mar 23. - Publication Year :
- 2019
-
Abstract
- Gender-affirming hormonal treatment (HT) in transgender people is considered safe in general, but the question regarding (long-term) risk on sex hormone-related cancer remains. Because the risk on certain types of cancer differs between men and women, and some of these differences are attributed to exposure to sex hormones, the cancer risk may be altered in transgender people receiving HT. Although reliable epidemiologic data are sparse, the available data will be discussed in this article. Furthermore, recommendations for cancer screening and prevention will be discussed as well as whether to withdraw HT at time of a cancer diagnosis.<br /> (Copyright © 2019 Elsevier Inc. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1558-4410
- Volume :
- 48
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Endocrinology and metabolism clinics of North America
- Publication Type :
- Academic Journal
- Accession number :
- 31027551
- Full Text :
- https://doi.org/10.1016/j.ecl.2019.02.005